Pulse Biosciences (PLSE) Non-Current Assets (2015 - 2025)

Pulse Biosciences' Non-Current Assets history runs 11 years deep, the most recent figure standing at $11.1 million for Q4 2025.

• On a quarterly basis, Non-Current Assets fell 14.55% year-over-year to $11.1 million in Q4 2025; TTM through Dec 2025 was $47.3 million, a 9.31% decrease from a year earlier, with the FY2025 full-year figure at $11.1 million, down 14.55% from the prior year.
• Non-Current Assets slipped to $11.1 million in Q4 2025 per PLSE's latest filing, from $11.6 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $18.6 million in Q1 2021 and bottomed at $11.1 million in Q4 2025.
• The 5-year median for Non-Current Assets is $14.1 million (2021), against an average of $14.6 million.
• Biggest YoY gain for Non-Current Assets was 20.58% in 2021; the steepest drop was 27.05% in 2021.
• Year by year, Non-Current Assets stood at $13.8 million in 2021, then climbed by 13.77% to $15.7 million in 2022, then fell by 12.1% to $13.8 million in 2023, then fell by 5.89% to $13.0 million in 2024, then fell by 14.55% to $11.1 million in 2025.
• Per Business Quant, the three latest PLSE Non-Current Assets figures stand at $11.1 million (Q4 2025), $11.6 million (Q3 2025), and $12.1 million (Q2 2025).